Patents by Inventor Ruth Rappaport

Ruth Rappaport has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sequence analysis of the tetravalent rotavirus vaccine
    Publication number: 20050119471
    Abstract: Isolated nucleic acid molecules comprising a gene segment from a rhesus rotavirus (RRV) or from one of three rhesus: human reassortant viruses are disclosed, including isolated nucleic acid molecules having a sequence selected from the group consisting of: SEQ ID NO: 1-14, inclusive, and isolated nucleic acid molecules encoding a protein having a sequence selected from the group consisting of SEQ ID NO: 15-28, inclusive, as well as variants of the isolated nucleic acid molecules.
    Type: Application
    Filed: February 19, 2003
    Publication date: June 2, 2005
    Applicant: THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Deborah Buonagurio, Alice Georgiu, Robert Lerch, Bruce Mason, Shridhara Murthy, Ruth Rappaport, Mohinder Sidhu, Stephen Udem, Timothy Zamb
  • Method of enchancing t-PA and SCU-PA production
    Patent number: 4889808
    Abstract: Disclosed herein is a method of enhancing the production of tissue plasminogen activator (t-PA) and single chain urokinase plasminogen activator (SCU-PA) by normal human lung diploid fibroblast cells in a serum-free medium. The method comprises the addition of heparin (or low molecular weight heparin) and an endothelial cell growth factor to the culture medium.
    Type: Grant
    Filed: September 17, 1986
    Date of Patent: December 26, 1989
    Assignee: American Home Products
    Inventor: Ruth Rappaport